ID: h-86d0aa1ede
Hypothesis
Rutin reduces ROS- and metal-driven tau oligomer nucleation
Chelation of redox-active metals and suppression of oxidative cross-linking reduce formation of toxic tau oligomers rather than binding mature fibrils directly.
EvidencePending (0%)📖 1 cit🗣 1 debates✓ 6 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
Chelation of redox-active metals and suppression of oxidative cross-linking reduce formation of toxic tau oligomers rather than binding mature fibrils directly.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Target Gene: MAPT"]
B["Molecular Mechanism<br/>Pathway Activation"]
C["Cellular Phenotype<br/>Neuronal / Glial Response"]
D["Network Effect<br/>Circuit-Level Consequence"]
E["Disease Relevance<br/>Neurodegeneration Link"]
A --> B --> C --> D --> E
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style E fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix6 supports1 contradicts
Supports
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
Supports
The Neuroprotective Potentiality of Flavonoids on Alzheimer's Disease.
Supports
Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation.
Supports
Phytomolecules as Alzheimer's therapeutics: A comprehensive review.
Supports
Study on the neuroprotective effects of Genistein on Alzheimer's disease.
Contradicts
Generic antioxidant effects may not explain structural selectivity for pathogenic tau seeds.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — MAPT
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for MAPT from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MAPT.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.6%
Volatility
Low
0.0027
Events (7d)
3
Price History
▼8.3%💾 Resource Usage
LLM Tokens
1,743
$0.0052
Total Cost
$0.0052
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF recombinant human 2N4R tau monomers (10 μM) are incubated with CuCl₂ (25 μM) plus H₂O₂ (100 μM) in the presence of rutin (100 μM), THEN the concentration of tau oligomers (measured by oligomer-spec | ≥50% reduction in tau oligomer concentration with no change in fibril elongation rate | — no observation — | pending | 0.72 |
| IF HEK293T cells transiently expressing 3×FLAG-hTau40 are pre-treated with rutin (30 μM) for 1 hour before exposure to 50 μM H₂O₂ for 2 hours, THEN intracellular tau oligomers (measured by amplified l | ≥40% reduction in oxidatively-induced tau oligomers with preserved total tau expression | — no observation — | pending | 0.68 |
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF recombinant human 2N4R tau monomers (10 μM) are incubated with CuCl₂ (25 μM) plus H₂O₂ (100 μM) in the presence of rutin (100 μM), THEN the concentration of tau oligomers (measured by oligomer-specific sandwich ELISA using the TOC1 antibody) will decrease by ≥50% compared to vehicle control withi
Predicted outcome: ≥50% reduction in tau oligomer concentration with no change in fibril elongation rate
Falsification: No significant reduction in tau oligomer concentration (<20% change) or any decrease in ThT signal indicating fibril disruption, which would indicate rutin acts on mature fibrils rather than nucleatio
pendingconf 68%
IF HEK293T cells transiently expressing 3×FLAG-hTau40 are pre-treated with rutin (30 μM) for 1 hour before exposure to 50 μM H₂O₂ for 2 hours, THEN intracellular tau oligomers (measured by amplified luminescence proximity assay) will decrease by ≥40% compared to H₂O₂-only controls at 24 hours post-t
Predicted outcome: ≥40% reduction in oxidatively-induced tau oligomers with preserved total tau expression
Falsification: No reduction or increase in tau oligomer levels despite antioxidant treatment, or reduction in total tau suggesting cytotoxicity rather than specific nucleation inhibition
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.